ESC 365 - Doctor Julius Nikorowitsch

Speaker illustration

Doctor Julius Nikorowitsch

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

Member of:

European Heart Rythm Association

Effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation. The NOAH-AFNET 6 trial.

Event: EHRA 2024

Topic: Oral Anticoagulation

Session: Late-Breaking Science: devices

Feasibility and outcomes of ultrasound-guided transcutaneous access to the axillary vein for implantation, revision, and upgrade of cardiac electronic devices

Event: EHRA 2024

Topic: Device Complications and Lead Extraction

Session: Poster session on devices, others

3 Tesla magnetic resonance imaging in patients with cardiac electronic implantable devices: a single center experience

Event: ESC Congress 2022

Topic: Device Treatment

Session: Device treatment of arrhythmias

Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach

Event: ESC Congress 2021 - The Digital Experience

Topic: Diagnostic Methods

Session: Highlights from the Young in heart failure

Head-to-head comparison of the incremental value of the three established risk markers hs-troponin I, hs-C-reactive protein and NT-proBNP in secondary prevention of coronary artery disease

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary Artery Disease (Chronic) ePosters

Predictive value of soluble urokinase-type plasminogen activator receptor for cardiovascular death and non-fatal myocardial infarction in patients with coronary artery disease

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary Artery Disease – Epidemiology, Prognosis, Outcome

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources